ADSK Financial Statements & Analysis
Complete financial statements for ADSK including income statement, balance sheet, and cash flow statement. Analyze ADSK's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
51
Neutral
Poor (0-40)Neutral (40-60)Good (60-100)
Income Statement
Revenue
12.4% ↑
Net Income
22.7% ↑
Gross Margin
-0.1% ↓
Operating Margin
11.7% ↑
Balance Sheet
Current Ratio
-17.8% ↓
Debt to Equity
-31.0% ↑
Asset Turnover
2.8% ↑
Cash Flow
Operating Cash Flow
22.4% ↑
Net Cash Flow
-432.7% ↓
Free Cash Flow
17.4% ↑
Cash Flow to Debt
25.6% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
Metric | 2024 | 2025 | Change | Impact |
---|---|---|---|---|
Revenue | 5.44B | 6.11B | 12.4% | |
Gross Profit | 4.89B | 5.49B | 12.2% | |
Operating Income | 1.11B | 1.40B | 25.5% | |
Net Income | 906.00M | 1.11B | 22.7% | |
EPS | 4.19 | 5.17 | 23.4% | |
EBITDA | 1.27B | 1.56B | 22.6% | |
Gross Margin | 89.83% | 89.74% | 0.1% | |
Operating Margin | 20.46% | 22.86% | 11.7% | |
Net Income Margin | 16.65% | 18.19% | 9.2% | |
R&D Expenses | 1.37B | 1.49B | 8.2% |
Income Statement Full Table
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 6.11B | 5.44B | 4.95B | 4.40B | 3.79B |
Gross Profit | 5.49B | 4.89B | 4.43B | 3.94B | 3.42B |
Operating Income | 1.40B | 1.11B | 992.00M | 660.80M | 639.30M |
Net Income | 1.11B | 906.00M | 823.00M | 497.00M | 1.21B |
EPS | 5.17 | 4.19 | 3.81 | 2.26 | 5.51 |
EBITDA | 1.56B | 1.27B | 1.17B | 789.00M | 720.80M |
Gross Margin | 89.74% | 89.83% | 89.54% | 89.59% | 90.12% |
Operating Margin | 22.86% | 20.46% | 20.06% | 15.02% | 16.86% |
Net Income Margin | 18.19% | 16.65% | 16.64% | 11.30% | 31.87% |
R&D Expenses | 1.49B | 1.37B | 1.21B | 1.11B | 933.00M |